Pages that link to "Q48158450"
Jump to navigation
Jump to search
The following pages link to Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. (Q48158450):
Displaying 50 items.
- Cdk5: multitasking between physiological and pathological conditions (Q24299163) (← links)
- Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor (Q24305253) (← links)
- Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice (Q24628256) (← links)
- Neuroprotective Mechanisms Mediated by CDK5 Inhibition (Q28082792) (← links)
- Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry (Q28200189) (← links)
- Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury (Q28383558) (← links)
- Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity (Q28565510) (← links)
- Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death (Q28568204) (← links)
- A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons (Q28576106) (← links)
- Early growth response 1 (Egr-1) regulates phosphorylation of microtubule-associated protein tau in mammalian brain (Q28578526) (← links)
- Cdk5 is a New Rapid Synaptic Homeostasis Regulator Capable of Initiating the Early Alzheimer-Like Pathology (Q30279162) (← links)
- Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25. (Q30613304) (← links)
- Heat shock protein 90: translation from cancer to Alzheimer's disease treatment? (Q30855123) (← links)
- Identification of small molecule inhibitors of beta-amyloid cytotoxicity through a cell-based high-throughput screening platform (Q33371464) (← links)
- No association of CDK5 genetic variants with Alzheimer's disease risk (Q33483663) (← links)
- Cdk5 activity in the brain - multiple paths of regulation (Q33687591) (← links)
- Molecular mechanisms of neurodegeneration in Alzheimer's disease (Q33871297) (← links)
- CDK5 interacts with Slo and affects its surface expression and kinetics through direct phosphorylation (Q34077155) (← links)
- A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains (Q34139509) (← links)
- Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles (Q34279396) (← links)
- Phosphorylation of glutamyl-prolyl tRNA synthetase by cyclin-dependent kinase 5 dictates transcript-selective translational control (Q34533775) (← links)
- Cdk5 behind the wheel: a role in trafficking and transport? (Q34537614) (← links)
- Cdk5 phosphorylation of EFhd2 at S74 affects its calcium binding activity (Q34571448) (← links)
- Cyclin-dependent kinase 5 promotes pancreatic β-cell survival via Fak-Akt signaling pathways. (Q34718758) (← links)
- p25/CDK5 is partially involved in neuronal injury induced by radiofrequency electromagnetic field exposure. (Q34779285) (← links)
- Spatial learning impairment, enhanced CDK5/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1. (Q34913399) (← links)
- Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer's disease. (Q35006021) (← links)
- Tau neurofibrillary pathology and microtubule stability (Q35050284) (← links)
- Gene discovery and validation for neurodegenerative diseases (Q35053214) (← links)
- Absence of the Cdk5 activator p35 causes adult-onset neurodegeneration in the central brain of Drosophila (Q35794568) (← links)
- Deregulated Cdk5 activity is involved in inducing Alzheimer's disease (Q36494716) (← links)
- Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing (Q36579740) (← links)
- Advances in the pathogenesis of Alzheimer's disease: focusing on tau-mediated neurodegeneration (Q36688393) (← links)
- Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease. (Q36784909) (← links)
- Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases. (Q36836607) (← links)
- Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice (Q37117419) (← links)
- The role of tau in neurodegeneration (Q37145919) (← links)
- Crosstalk between Cdk5 and GSK3beta: Implications for Alzheimer's Disease (Q37223230) (← links)
- Pharmacotherapeutic targets in Alzheimer's disease (Q37295067) (← links)
- Calcium in the initiation, progression and as an effector of Alzheimer's disease pathology (Q37570600) (← links)
- Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies (Q37606284) (← links)
- Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion (Q38108308) (← links)
- Neuroprotective function of 14-3-3 proteins in neurodegeneration (Q38173380) (← links)
- Protein phosphorylation in neurodegeneration: friend or foe? (Q38214594) (← links)
- Invited review: Animal models of tauopathies and their implications for research/translation into the clinic (Q38271896) (← links)
- Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau. (Q38313548) (← links)
- Phosphorylation of collapsin response mediator protein-2 disrupts neuronal maturation in a model of adult neurogenesis: Implications for neurodegenerative disorders (Q38868081) (← links)
- New Functions of APC/C Ubiquitin Ligase in the Nervous System and Its Role in Alzheimer's Disease (Q39307016) (← links)
- Identification of non-muscle myosin heavy chain as a substrate for Cdk5 and tool for drug screening (Q39836825) (← links)
- Abl deregulates Cdk5 kinase activity and subcellular localization in Drosophila neurodegeneration (Q40239614) (← links)